Ethnic differences in peripheral vascular disease

International Journal of Clinical Practice

Volumn 56, Issue 8, 2002, Pages 605-608

  Makin, A ^a   Silverman, S ^a   Lip, G Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANGIOGRAPHY; ARTERY DISEASE; ASIAN; ATHEROSCLEROSIS; BUERGER DISEASE; CAUCASIAN; CLINICAL FEATURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE SEVERITY; ETHNIC DIFFERENCE; ETHNIC GROUP; HUMAN; INTERMITTENT CLAUDICATION; PATHOPHYSIOLOGY; PERIPHERAL VASCULAR DISEASE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; RISK FACTOR;

ADOLESCENT; ADULT; AFRICA; AGED; BARBADOS; BLOOD COAGULATION DISORDERS; CHILD; CHILD, PRESCHOOL; DIABETES COMPLICATIONS; FEMALE; GREAT BRITAIN; HUMANS; HYPERTENSION; INDONESIA; LIPIDS; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PREVALENCE; RISK FACTORS; SMOKING;

EID: 0036775546     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (38)

1. Kannel WB. The demographics of claudication and the aging of the American population. Vasc Med 1996; 1(1): 60-64.
2. TransAtlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease (PAD). Eur J Vasc Endovasc Surg 2000; 19(suppl A): Si-250.
3. Senior PA, Bhopal R. Ethnicity as a variable in epidemiological research. BMJ 1994; 309: 327-330.
4. Bhopal R, Unwin N, White M et al. Heterogeneity of coronary heart disease risk factors in Indian, Pakistani, Bangladeshi, and European origin populations: cross sectional study. BMJ 1999; 319: 215-220.
5. Lesauskaite V, Tanganelli P, Bianciardi G et al. World Health Organization (WHO) and the World Heart Federation (WHF) Pathobiological Determinants of Atherosclerosis in Youth (PBDAY) Study. Histomorphometric investigation of the aorta and coronary arteries in young people from different geographical locations. Nutr Metab Cardiovasc Dis 1999; 9(6): 266-276.
6. Renaud S, de Lorgeril M. Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992; 339: 1523-1526.
7. Tsai AW, Folsom AR, Rosamond WD, Jones DW. Ankle-brachial index and 7-year ischemic stroke incidence: the ARIC study. Stroke 2001; 32(8): 1721-1724.
8. Shead GV, Oomen RM, Savarirayan SS. The pattern of non-diabetic peripheral vascular disease in South India. Br J Surg 1978; 65(1): 49-53.
9. Mohan V, Premalatha G, Sastry NG. Peripheral vascular disease in non-insulin-dependent diabetes mellitus in south India. Diabetes Res Clin Pract 1995; 27(3): 235-240.
10. Lee AJ, MacGregor AS, Hau CM et al. The role of haematological factors in diabetic peripheral arterial disease: the Edinburgh artery study. Br J Haematol 1999; 105(3): 648-654.
11. Salomaa V, Matei C, Aleksic N et al. Cross-sectional association of soluble thrombomodulin with mild peripheral artery disease; the ARIC study. Atherosclerosis 2001; 157(2): 309-314.
12. Gordon WC Jr, Freeman JM, Roberts MH. A new look at peripheral vascular disease in blacks: a two-year update. J Natl Med Assoc 1980; 72(12): 1177-1183.
13. Wysokinski WE, Kwiatkowska W, Sapian-Raczkowska B et al. Sustained classic clinical spectrum of thromboangiitis obliterans (Buerger's disease). Angiology 2000; 51(2): 141-150.
14. Lie JT. The rise and fall and resurgence of thromboangiitis obliterans (Buerger's disease). Acta Pathol Jpn 1989; 39(3): 153-158.
15. Fleshman K. Buerger's disease in Nepal. Trop Doc 1998; 28(4): 203-206.
16. Matsushita M, Nishikimi N, Sakurai T, Nimura Y. Decrease in prevalence of Buerger's disease in Japan. Surgery 1998; 124(3): 498-502.
17. Kinare SG, Kher YR, Rao G, Sen PK. Pattern of occlusive peripheral vascular disease in India (clinicopathological study of 79 cases). Angiology 1976; 27(3): 165-180.
18. Haffner SM. Epidemiology of type 2 diabetes: risk factors. Diabetes Care 1998; 21(suppl 3):C3-C6.
19. Ramachandran A, Snehalatha C, Viswanathan V et al. Risk of noninsulin dependent diabetes mellitus conferred by obesity and central adiposity in different ethnic groups: a comparative analysis between Asian Indians, Mexican Americans and Whites. Diabetes Res Clin Pract 1997; 36(2): 121-125.
20. Ramachandran A, Snehalatha C, Sasikala R et al. Vascular complications in young Asian Indian patients with type 1 diabetes mellitus. Diabetes Res Clin Pract 2000; 48(1): 51-56.
21. Janka HU, Standl E, Mehnert H. Peripheral vascular disease in diabetes mellitus and its relation to cardiovascular risk factors: screening with the doppler ultrasonic technique. Diabetes Care 1980; 3(2): 207-213.
22. Samanta A, Burden AC, Jagger C. A comparison of the clinical features and vascular complications of diabetes between migrant Asians and Caucasians in Leicester, UK. Diabetes Res Clin Pract 1991; 14(3): 205-213.
23. Fernando DJ, Siribaddana. S, Perera N et al. The prevalence of macrovascular disease and lipid abnormalities amongst diabetic patients in Sri Lanka. Postgrad Med J 1993; 69(813): 557-561.
24. Trayner IM, Mannarino E, Clyne CA, Thompson GR. Serum lipids and high density lipoprotein cholesterol in peripheral vascular disease. Br J Surg 1980; 67(7): 497-499.
25. Keenan JP, Robbs JV. Lipid profiles in peripheral vascular disease: a comparison between blacks and whites. S Afr J Surg 1985; 23(1): 15-17.
26. Whitty CJ, Brunner EJ, Shipley MJ et al. Differences in biological risk factors for cardiovascular disease between three ethnic groups in the Whitehall II study. Atherosclerosis 1999; 142(2): 279-286.
27. Ezenwaka CE, Premanand N, Orrett FA. Studies on plasma lipids in industrial workers in central Trinidad and Tobago. J Natl Med Assoc 2000; 92(8): 375-381.
28. Dhawan J, Bray CL, Warburton R et al. Insulin resistance, high prevalence of diabetes, and cardiovascular risk in immigrant Asians: genetic or environmental effect? Br Heart J 1994; 72(5): 413-421.
29. Simmons D, Powell MJ. Metabolic and clinical characteristics of south Asians and Europeans in Coventry. Diabet Med 1993; 10(8): 751-758.
30. Anand SS, Yusuf S, Vuksan V et al. Differences in risk factors, atherosclerosis, and cardiovascular disease between ethnic groups in Canada: the Study of Health Assessment and Risk in Ethnic groups (SHARE). Lancet 2000; 356: 279-284.
31. Kannel WB, McGee DL. Update on some epidemiologic features of intermittent claudication: the Framingham Study. J Am Geriatr Soc 1985; 33(1): 13-18.
32. Smith FB, Lee AJ, Hau CM et al. Plasma fibrinogen, haemostatic factors and prediction of peripheral arterial disease in the Edinburgh Artery Study. Blood Coagul Fibrinolysis 2000; 11(1): 43-50.
33. Fowkes FG, Lowe GD, Housley E et al. Cross-linked fibrin degradation products, progression of peripheral arterial disease, and risk of coronary heart disease. Lancet 1993; 342: 84-86.
34. Meade TW, Brozovic M, Chakrabarti R et al. Ethnic group comparisons of variables associated with ischaemic heart disease. Br Heart J 1978; 40(7): 789-795.
35. Valentine RJ, Grayburn PA, Vega GL, Grundy SM. Lp(a) lipoprotein is an independent, discriminating risk factor for premature peripheral atherosclerosis among white men. Arch Intern Med 1994; 154(7): 801-806.
36. Brown SA, Morrisett JD, Boerwinkle E et al. The relation of lipoprotein (a) concentrations and apolipoprotein(a) phenotypes with asymptomatic atherosclerosis in subjects of the Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb 2001; 13: 1558-1566.
37. Fraga A, Medina F. Takayasu's arteritis. Curr Rheumatol Rep 2002; 4(1): 30-38.
38. Nahas GG. Cannabis arteritis. N Engl J Med 1971; 284(2): 113.